Drug Ther Bull. 2015 Apr;53(4):45-8. doi: 10.1136/dtb.2015.4.0322.
In 2009, DTB published an editorial calling for the abolition of the NHS prescription charge.1 The article highlighted that from April 2011, England would be the only UK country that would tax patients for medicines through levying a prescription charge. In addition, it noted that the categorisation of medical and other exemptions is illogical and that the prescription charge is a poorly conceived, manifestly unfair tax. Of particular concern is the impact of the prescription charge on patients with chronic conditions that do not fall into the exemption categories. For many years the Prescription Charges Coalition, an alliance of more than 30 organisations concerned with the impact of prescription charges on people with long-term conditions, has campaigned to extend exemption from prescription charges to all those with long-term conditions.2 A subsequent DTB editorial, published in 2014, discussed anomalies associated with the prescription charge, including the cost of administering the bureaucracy needed to underpin the collection and checking of exemptions, and management of pre-payment certification.3 The editorial repeated the call for prescription charges to be abolished. Revisiting these themes, here we present an overview of the results of a survey conducted to explore the views of healthcare professionals on the NHS prescription charge.
2009年,《药物与治疗通报》发表了一篇社论,呼吁废除英国国家医疗服务体系(NHS)的处方收费。1 该文章强调,自2011年4月起,英格兰将成为英国唯一一个通过征收处方费对患者的药品征税的国家。此外,它指出医疗和其他豁免的分类不合逻辑,且处方费是一种构思不佳、明显不公平的税收。特别令人担忧的是处方费对不属于豁免类别的慢性病患者的影响。多年来,由30多个关注处方费对长期病患者影响的组织组成的处方费联盟一直在开展活动,争取将处方费豁免范围扩大到所有长期病患者。2 《药物与治疗通报》随后在2014年发表的一篇社论讨论了与处方费相关的异常情况,包括为支持豁免的收集和核查所需的官僚机构管理成本以及预付费证明的管理。3 该社论再次呼吁废除处方费。在此重温这些主题,我们概述了一项为探索医疗保健专业人员对NHS处方费的看法而进行的调查结果。